Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 319

1.

Use of kZ -space for high through-plane resolution in multislice MRI: Application to prostate.

Kargar S, Borisch EA, Froemming AT, Grimm RC, Kawashima A, King BF, Stinson EG, Riederer SJ.

Magn Reson Med. 2019 Jun;81(6):3691-3704. doi: 10.1002/mrm.27691. Epub 2019 Mar 7.

PMID:
30844092
2.

Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic.

Yoshida K, Takahashi N, King BF, Kawashima A, Harris PC, Cornell LD, Cornec-Le Gall E, Inoue D, Mizushima I, Kawano M, Thervet E, de Cotret PR, Torres VE.

Eur Radiol. 2019 Feb 26. doi: 10.1007/s00330-019-06057-3. [Epub ahead of print]

PMID:
30806804
3.

Safety and Image Quality of 1.5-T Endorectal Coil Multiparametric MRI of the Prostate or Prostatectomy Fossa for Patients With Pacemaker or Implantable Cardioverter-Defibrillator.

Tanaka T, Froemming AT, Panda A, Edmonson HA, Pooley RA, Carter RE, King BF, Kawashima A.

AJR Am J Roentgenol. 2019 Apr;212(4):815-822. doi: 10.2214/AJR.18.20266. Epub 2019 Jan 30.

PMID:
30699008
4.

Complications of Intravesical BCG Immunotherapy for Bladder Cancer.

Green DB, Kawashima A, Menias CO, Tanaka T, Redelman-Sidi G, Bhalla S, Shah R, King BF.

Radiographics. 2019 Jan-Feb;39(1):80-94. doi: 10.1148/rg.2019180014. Epub 2018 Dec 7.

PMID:
30526332
5.

Artificial Intelligence and Radiology: What Will the Future Hold?

King BF Jr.

J Am Coll Radiol. 2018 Mar;15(3 Pt B):501-503. doi: 10.1016/j.jacr.2017.11.017. Epub 2018 Jan 19. No abstract available.

PMID:
29371088
6.

Guest Editorial: Discovery and Artificial Intelligence.

King BF Jr.

AJR Am J Roentgenol. 2017 Dec;209(6):1189-1190. doi: 10.2214/AJR.17.19178. No abstract available.

PMID:
29161146
7.

Quantitative MRI of kidneys in renal disease.

Kline TL, Edwards ME, Garg I, Irazabal MV, Korfiatis P, Harris PC, King BF, Torres VE, Venkatesh SK, Erickson BJ.

Abdom Radiol (NY). 2018 Mar;43(3):629-638. doi: 10.1007/s00261-017-1236-y.

8.

Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys.

Kline TL, Korfiatis P, Edwards ME, Blais JD, Czerwiec FS, Harris PC, King BF, Torres VE, Erickson BJ.

J Digit Imaging. 2017 Aug;30(4):442-448. doi: 10.1007/s10278-017-9978-1.

9.

Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease.

Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ; CRISP Investigators.

Kidney Int. 2017 Nov;92(5):1206-1216. doi: 10.1016/j.kint.2017.03.026. Epub 2017 May 20.

10.

CT-guided transgluteal biopsy for systematic sampling of the prostate in patients without rectal access: a 13-year single-center experience.

Olson MC, Atwell TD, Mynderse LA, King BF, Welch T, Goenka AH.

Eur Radiol. 2017 Aug;27(8):3326-3332. doi: 10.1007/s00330-016-4694-7. Epub 2016 Dec 14.

PMID:
27975149
11.

Predictors of prostate volume reduction following neoadjuvant cytoreductive androgen suppression.

Jethwa KR, Furutani KM, Mynderse LA, Wilson TM, Choo R, King BF, Bergstralh E, Davis BJ.

J Contemp Brachytherapy. 2016 Oct;8(5):371-378. Epub 2016 Nov 4.

12.

Inherited renal cystic diseases.

Kim B, King BF Jr, Vrtiska TJ, Irazabal MV, Torres VE, Harris PC.

Abdom Radiol (NY). 2016 Jun;41(6):1035-51. doi: 10.1007/s00261-016-0754-3. Review.

PMID:
27167233
13.

Inherited renal carcinomas.

Kawashima A, Young SW, Takahashi N, King BF, Atwell TD.

Abdom Radiol (NY). 2016 Jun;41(6):1066-78. doi: 10.1007/s00261-016-0743-6. Review.

PMID:
27108134
14.

Inflatable penile prosthesis (IPP): diagnosis of complications.

Hartman RP, Kawashima A, Takahashi N, LeRoy AJ, King BF.

Abdom Radiol (NY). 2016 Jun;41(6):1187-96. doi: 10.1007/s00261-016-0686-y. Review.

PMID:
26907716
15.

Severe Acute Cardiopulmonary Failure Related to Gadobutrol Magnetic Resonance Imaging Contrast Reaction: Successful Resuscitation With Extracorporeal Membrane Oxygenation.

Guru PK, Bohman JK, Fleming CJ, Tan HL, Sanghavi DK, De Moraes AG, Barsness GW, Wittwer ED, King BF, Arteaga GM, Flick R, Schears GJ.

Mayo Clin Proc. 2016 Mar;91(3):362-6. doi: 10.1016/j.mayocp.2015.12.010. Epub 2016 Feb 5.

PMID:
26856779
16.

Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.

Zand L, Torres VE, Larson TS, King BF, Sethi S, Bergstralh EJ, Angioi A, Fervenza FC.

Nephrol Dial Transplant. 2016 Aug;31(8):1290-5. doi: 10.1093/ndt/gfv394. Epub 2015 Nov 27.

17.

Automatic total kidney volume measurement on follow-up magnetic resonance images to facilitate monitoring of autosomal dominant polycystic kidney disease progression.

Kline TL, Korfiatis P, Edwards ME, Warner JD, Irazabal MV, King BF, Torres VE, Erickson BJ.

Nephrol Dial Transplant. 2016 Feb;31(2):241-8. doi: 10.1093/ndt/gfv314. Epub 2015 Aug 31.

18.

Purinergic signalling in the enteric nervous system (An overview of current perspectives).

King BF.

Auton Neurosci. 2015 Sep;191:141-7. doi: 10.1016/j.autneu.2015.05.005. Epub 2015 May 22. Review.

PMID:
26049261
19.

Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease.

Kline TL, Irazabal MV, Ebrahimi B, Hopp K, Udoji KN, Warner JD, Korfiatis P, Mishra PK, Macura SI, Venkatesh SK, Lerman LO, Harris PC, Torres VE, King BF, Erickson BJ.

Magn Reson Med. 2016 Apr;75(4):1466-73. doi: 10.1002/mrm.25701. Epub 2015 May 13.

20.

Early localization of recurrent prostate cancer after prostatectomy by endorectal coil magnetic resonance imaging.

Linder BJ, Kawashima A, Woodrum DA, Tollefson MK, Karnes J, Davis BJ, Rangel LJ, King BF, Mynderse LA.

Can J Urol. 2014 Jun;21(3):7283-9.

PMID:
24978358
21.

Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials.

Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, Hogan MC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, Torres VE; CRISP Investigators.

J Am Soc Nephrol. 2015 Jan;26(1):160-72. doi: 10.1681/ASN.2013101138. Epub 2014 Jun 5.

22.

Supervised segmentation of polycystic kidneys: a new application for stereology data.

Warner JD, Irazabal MV, Krishnamurthi G, King BF, Torres VE, Erickson BJ.

J Digit Imaging. 2014 Aug;27(4):514-9. doi: 10.1007/s10278-014-9679-y.

23.

A new owl species of the genus Otus (aves: strigidae) from Lombok, Indonesia.

Sangster G, King BF, Verbelen P, Trainor CR.

PLoS One. 2013;8(2):e53712. doi: 10.1371/journal.pone.0053712. Epub 2013 Feb 13.

24.

Role of kidney Doppler ultrasonography in the diagnosis and management of anuric kidney failure.

Zand L, King BF, Qian Q.

Clin Nephrol. 2014 Aug;82(2):122-7. doi: 10.5414/CN107765.

PMID:
23253907
25.

Utility of gadolinium-enhanced MR urography in detection of bladder carcinoma.

Niederhauser BD, Kawashima A, King BF, Takahashi N.

Eur J Radiol. 2013 Mar;82(3):472-7. doi: 10.1016/j.ejrad.2012.10.033. Epub 2012 Dec 11.

PMID:
23238362
26.

Somatostatin analog therapy for severe polycystic liver disease: results after 2 years.

Hogan MC, Masyuk TV, Page L, Holmes DR 3rd, Li X, Bergstralh EJ, Irazabal MV, Kim B, King BF, Glockner JF, Larusso NF, Torres VE.

Nephrol Dial Transplant. 2012 Sep;27(9):3532-9. doi: 10.1093/ndt/gfs152. Epub 2012 Jul 6.

27.

Resolution and concordance in dissecting the compound inhibitory junction potential.

King BF.

J Physiol. 2012 Apr 15;590(8):1777-8. doi: 10.1113/jphysiol.2012.230110. No abstract available.

28.

Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease.

Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, Grantham JJ.

Clin J Am Soc Nephrol. 2012 Mar;7(3):479-86. doi: 10.2215/CJN.09500911. Epub 2012 Feb 16.

29.

MRI and its role in the evaluation and surgical decision making in patients with challenging IPP presentations: descriptions of MRI findings and algorithm for patient management.

McPhail EF, Nehra A, Bruner BC, Kawashima A, King BF, Kim B.

BJU Int. 2012 Jun;109(12):1848-52. doi: 10.1111/j.1464-410X.2011.10683.x. Epub 2011 Oct 28.

30.

Imaging evaluation of amyloidosis of the urinary tract and retroperitoneum.

Kawashima A, Alleman WG, Takahashi N, Kim B, King BF Jr, LeRoy AJ.

Radiographics. 2011 Oct;31(6):1569-82. doi: 10.1148/rg.316115519. Review.

PMID:
21997982
31.

White paper from the ACR Task Force on Print Media in Radiology.

Duszak R Jr, Haines GR, Van Duyn Wear V, Lexa FJ, Bashir M, D'Souza S, Carlos R, Chen JY, King BF, Wald C.

J Am Coll Radiol. 2011 Oct;8(10):692-702. doi: 10.1016/j.jacr.2011.06.018. Review.

PMID:
21962783
32.

Short-term effects of tolvaptan on renal function and volume in patients with autosomal dominant polycystic kidney disease.

Irazabal MV, Torres VE, Hogan MC, Glockner J, King BF, Ofstie TG, Krasa HB, Ouyang J, Czerwiec FS.

Kidney Int. 2011 Aug;80(3):295-301. doi: 10.1038/ki.2011.119. Epub 2011 May 4.

33.

Potentially modifiable factors affecting the progression of autosomal dominant polycystic kidney disease.

Torres VE, Grantham JJ, Chapman AB, Mrug M, Bae KT, King BF Jr, Wetzel LH, Martin D, Lockhart ME, Bennett WM, Moxey-Mims M, Abebe KZ, Lin Y, Bost JE; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Clin J Am Soc Nephrol. 2011 Mar;6(3):640-7. doi: 10.2215/CJN.03250410. Epub 2010 Nov 18.

34.

Incidental findings in imaging research: evaluating incidence, benefit, and burden.

Orme NM, Fletcher JG, Siddiki HA, Harmsen WS, O'Byrne MM, Port JD, Tremaine WJ, Pitot HC, McFarland EG, Robinson ME, Koenig BA, King BF, Wolf SM.

Arch Intern Med. 2010 Sep 27;170(17):1525-32. doi: 10.1001/archinternmed.2010.317.

35.

Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease.

Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR 3rd, Rossetti S, Harris PC, LaRusso NF, Torres VE.

J Am Soc Nephrol. 2010 Jun;21(6):1052-61. doi: 10.1681/ASN.2009121291. Epub 2010 Apr 29.

36.

Renal arterial blood flow measurement by breath-held MRI: Accuracy in phantom scans and reproducibility in healthy subjects.

Dambreville S, Chapman AB, Torres VE, King BF, Wallin AK, Frakes DH, Yoganathan AP, Wijayawardana SR, Easley K, Bae KT, Brummer ME; Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP).

Magn Reson Med. 2010 Apr;63(4):940-50. doi: 10.1002/mrm.22278.

37.

Gadolinium enhanced magnetic resonance urography for upper urinary tract malignancy.

Takahashi N, Glockner JF, Hartman RP, King BF, Leibovich BC, Stanley DW, Fitz-Gibbon PD, Kawashima A.

J Urol. 2010 Apr;183(4):1330-65. doi: 10.1016/j.juro.2009.12.031. Epub 2010 Feb 19.

PMID:
20171676
38.

Acute bilateral renal vein thrombosis.

Qian Q, Saucier NA, King BF.

Am J Kidney Dis. 2009 Nov;54(5):975-8. doi: 10.1053/j.ajkd.2009.06.035. Epub 2009 Sep 12. No abstract available.

PMID:
19748714
39.

Imaging of the seminal vesicle and vas deferens.

Kim B, Kawashima A, Ryu JA, Takahashi N, Hartman RP, King BF Jr.

Radiographics. 2009 Jul-Aug;29(4):1105-21. doi: 10.1148/rg.294085235. Review.

PMID:
19605659
40.

Nucleotides downregulate aquaporin 2 via activation of apical P2 receptors.

Wildman SS, Boone M, Peppiatt-Wildman CM, Contreras-Sanz A, King BF, Shirley DG, Deen PM, Unwin RJ.

J Am Soc Nephrol. 2009 Jul;20(7):1480-90. doi: 10.1681/ASN.2008070686. Epub 2009 May 7.

41.

ENaC, renal sodium excretion and extracellular ATP.

Wildman SS, Kang ES, King BF.

Purinergic Signal. 2009 Dec;5(4):481-9. doi: 10.1007/s11302-009-9150-6. Epub 2009 Mar 21.

42.

Spatial resolution and radiation dose of a 64-MDCT scanner compared with published CT urography protocols.

Vrtiska TJ, Hartman RP, Kofler JM, Bruesewitz MR, King BF, McCollough CH.

AJR Am J Roentgenol. 2009 Apr;192(4):941-8. doi: 10.2214/AJR.07.2679.

PMID:
19304698
43.

MR urography for suspected upper tract urothelial carcinoma.

Takahashi N, Kawashima A, Glockner JF, Hartman RP, Kim B, King BF.

Eur Radiol. 2009 Apr;19(4):912-23. doi: 10.1007/s00330-008-1228-y. Epub 2008 Nov 27.

PMID:
19037644
44.

Benign and malignant epididymal masses evaluated with scrotal sonography: clinical and pathologic review of 85 patients.

Alleman WG, Gorman B, King BF, Larson DR, Cheville JC, Nehra A.

J Ultrasound Med. 2008 Aug;27(8):1195-202.

PMID:
18645078
45.

Roles of ectodomain and transmembrane regions in ethanol and agonist action in purinergic P2X2 and P2X3 receptors.

Asatryan L, Popova M, Woodward JJ, King BF, Alkana RL, Davies DL.

Neuropharmacology. 2008 Oct;55(5):835-43. doi: 10.1016/j.neuropharm.2008.06.044. Epub 2008 Jun 29.

46.

P2X receptors: epithelial ion channels and regulators of salt and water transport.

Wildman SS, King BF.

Nephron Physiol. 2008;108(3):p60-7. doi: 10.1159/000122028. Epub 2008 Mar 29. Review.

47.

Small (<2-cm) upper-tract urothelial carcinoma: evaluation with gadolinium-enhanced three-dimensional spoiled gradient-recalled echo MR urography.

Takahashi N, Kawashima A, Glockner JF, Hartman RP, Leibovich BC, Brau AC, Beatty PJ, King BF.

Radiology. 2008 May;247(2):451-7. doi: 10.1148/radiol.2472070798. Epub 2008 Mar 27.

PMID:
18372452
48.

Sodium-dependent regulation of renal amiloride-sensitive currents by apical P2 receptors.

Wildman SS, Marks J, Turner CM, Yew-Booth L, Peppiatt-Wildman CM, King BF, Shirley DG, Wang W, Unwin RJ.

J Am Soc Nephrol. 2008 Apr;19(4):731-42. doi: 10.1681/ASN.2007040443. Epub 2008 Jan 30.

49.

Sirolimus reduces polycystic liver volume in ADPKD patients.

Qian Q, Du H, King BF, Kumar S, Dean PG, Cosio FG, Torres VE.

J Am Soc Nephrol. 2008 Mar;19(3):631-8. doi: 10.1681/ASN.2007050626. Epub 2008 Jan 16.

50.

Involvement of P2Y1 and P2Y11 purinoceptors in parasympathetic inhibition of colonic smooth muscle.

King BF, Townsend-Nicholson A.

J Pharmacol Exp Ther. 2008 Mar;324(3):1055-63. Epub 2007 Nov 29.

PMID:
18048695

Supplemental Content

Support Center